Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 18;5(14):e129700.
doi: 10.1172/jci.insight.129700.

Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults

Affiliations
Randomized Controlled Trial

Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults

Victoria J Williams et al. JCI Insight. .

Abstract

Background: There is growing evidence to suggest that the brain is an important target for insulin action, and that states of insulin resistance may extend to the CNS with detrimental effects on cognitive functioning. Although the effect of systemic insulin resistance on peripheral organs is well-studied, the degree to which insulin impacts brain function in vivo remains unclear.

Methods: This randomized, single-blinded, 2-way-crossover, sham-controlled, pilot study determined the effects of hyperinsulinemia on fMRI brain activation during a 2-back working memory task in 9 healthy older adults (aged 57-79 years). Each participant underwent two clamp procedures (an insulin infusion and a saline placebo infusion, with normoglycemia maintained during both conditions), to examine the effects of hyperinsulinemia on task performance and associated blood-oxygen-level dependent (BOLD) signal using fMRI.

Results: Hyperinsulinemia (compared to saline control) was associated with an increase in both the spatial extent and relative strength of task-related BOLD signal during the 2-back task. Further, the degree of increased task-related activation in select brain regions correlated with greater systemic insulin sensitivity, as well as decreased reaction times and performance accuracy between experimental conditions.

Conclusion: Together, these findings provide evidence of insulin action in the CNS among older adults during periods of sustained cognitive demand, with the greatest effects noted for individuals with highest systemic insulin sensitivity.

Funding: This work was funded by the National Institutes of Health (5R21AG051958, 2016).

Keywords: Aging; Endocrinology; Insulin; Insulin signaling; Neuroimaging.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: AMK has held full-time employment at Biogen and Sage Therapeutics, from which he earned a salary and received stock options. SJR is listed as a co-inventor on the following published US patents and patent applications on aspects of the bionic pancreas (US 9,833,570 and US 10,188,795; US patent application: 20180220942); these patents are assigned to Massachusetts General Hospital and are licensed to Beta Bionics; has received honoraria and/or travel expenses for lectures from Dexcom, Eli Lilly, Tandem Diabetes, Sanofi, Novo Nordisk, Roche, and Ascensia; serves on the scientific advisory boards for Unomedical and Companion Medical; has served on a scientific advisory board for Tandem Diabetes; has received consulting fees from Senseonics and Flexion Therapeutics; has received grant support from Zealand Pharma, Novo Nordisk, and Beta Bionics; and has received in-kind support in the form of technical support and/or donation of materials from Eli Lilly, Zealand Pharma, Dexcom, Ascensia, Senseonics, Adocia, and Tandem Diabetes. SEA has received honoraria and/or travel expenses for lectures from AbbVie, Biogen, Merck, and Roche; has served on scientific advisory boards for Merck, Roche, T3D, and vTv; has received consulting fees from Cognito Therapeutics, M3 Biotechnology, Orthogonal Neuroscience, and Pain Therapeutics; and has received research grant support from AbbVie, Amylyx, EIP Pharma, and Merck.

Figures

Figure 1
Figure 1. Spatial overlap of task-related fMRI activation for 2-back greater than 0-back trials during insulin and saline conditions analyzed separately.
(A) Conjunction map showing the spatial overlap from 1-sample group mean analyses of task-related activation for 2-back to 0-back trials for insulin and saline conditions analyzed separately (n = 9; P < 0.01, corrected). An expected pattern of task-related activation was observed across both conditions largely involving frontal and parietal regions, although the spatial extent of activation was 1.8 times larger during insulin compared with saline condition. (B) Results from each 2-back to 0-back contrast analyzed separately by experimental condition (insulin and saline) contributing to the conjunction map above, resampled onto the cortical surface for ease of viewing.
Figure 2
Figure 2. Brain areas showing significantly increased task-related fMRI activation during insulin compared to saline conditions, and regional associations with task performance and baseline insulin sensitivity.
(A) Cluster-based results of a 2-step higher-level analysis to evaluate average within-subject difference in 2-back to 0-back contrast between insulin and saline conditions (n = 9). First, subject-level repeated-measure analysis was performed to yield a single cope comparing blood oxygen level–dependent (BOLD) signal during the contrast of interest (2-back to 0-back) between insulin and saline runs. Next, each within-subject difference cope was entered into a single 1-sample group mean regression model to identify brain regions that consistently demonstrated a change in BOLD signal during the 2-back task between the insulin and saline conditions, such that the mean change in activation across all participants was significantly different from the null hypothesis of no change. Final Z-statistic maps were thresholded using clusters determined by Z > 2.3 (P < 0.01) and a corrected cluster significance threshold of P < 0.05. Significant differences in task-related BOLD signal were noted in bilateral inferior frontal, parahippocampal, precuneus, and thalamic regions, as well as lateralized clusters within right superior frontal, right supramarginal, and left middle frontal cortices. (B) Scatter plots demonstrating significant bivariate correlations between the degree of BOLD signal parameter estimate (PE) change during insulin compared with saline conditions and difference in RT on 2-back trials between conditions (n = 9; P < 0.05 for all). Colored outline around scatter plots corresponds to the matching cluster color from which its data were extracted. Clusters are described in greater detail in Table 4 (cluster 5, left fusiform/supramarginal gyrus; cluster 8, bilateral precuneus; cluster 9, right supramarginal/angular gyrus; and cluster 10, right inferior frontal cortex).
Figure 3
Figure 3. Scatter plot demonstrating a significant positive bivariate correlation between increased task-related activation during the insulin compared with saline clamp, quantified as a change in BOLD signal PE and hyperinsulinemic euglycemic clamp–insulin sensitivity index (HEC-ISI) within the bilateral precuneus (cluster 8); n = 9.
Figure 4
Figure 4. Overview of study procedures.
(A) Overview of study timeline for each experimental visit (insulin and saline clamp conditions) conducted within the Massachusetts General Hospital, Clinical Research Center (CRC). Each infusion condition was implemented following an overnight 12-hour fast. Study tasks (consisting of electroencephalography [EEG], cognitive testing, and functional MRI [fMRI]) commenced as soon as steady state was achieved. (B) Schematic of clamp setup. A continuous infusion of either insulin or saline was administered alongside a variable dextrose infusion to maintain normoglycemia, as indicated by 5-minute-interval blood glucose level checks. (C) Overview of N-back working memory task that was given during each fMRI session concurrently with infusion procedure. For the 2-back trials, participants were required to respond by button press if the letter presented was exactly the same as 2 stimuli before. For the 0-back control trials, participants were instructed to press a response button immediately upon seeing the letter X.

References

    1. [No authors listed]. National Diabetes Statistics Report, 2017. Centers for Disease Control Prevention. https://www.cdc.gov/diabetes/data/statistics-report/index.html Update March 6, 2018. Accessed July 11, 2019.
    1. Burns JM, Honea RA, Vidoni ED, Hutfles LJ, Brooks WM, Swerdlow RH. Insulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and aging. Biochim Biophys Acta. 2012;1822(3):333–339. - PMC - PubMed
    1. Young SE, Mainous AG, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29(12):2688–2693. doi: 10.2337/dc06-0915. - DOI - PubMed
    1. Willette AA, et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care. 2013;36(2):443–449. doi: 10.2337/dc12-0922. - DOI - PMC - PubMed
    1. Ryu SY, Coutu JP, Rosas HD, Salat DH. Effects of insulin resistance on white matter microstructure in middle-aged and older adults. Neurology. 2014;82(21):1862–1870. doi: 10.1212/WNL.0000000000000452. - DOI - PMC - PubMed

Publication types